How Patient Advocacy Groups can Boost Patient Compliance
Andrew Tolve, (Mar 9, 2010)Andrew Tolve reports on the role of patient advocacy groups in helping pharma firms improve adherence rates.
Welcome to eyeforpharma. Our aim is to make pharma companies better. To find out more, click here.
To cut straight to the action, choose a section from the menu above. Also follow us on twitter, subscribe to one of our monthly newsletters or find out about our upcoming conferences and events.
Patient Compliance and Specialty Pharmacy Products
Les Rose, (Mar 9, 2010)Kevin Cast, VP of CuraScript, on how adherence can boost cost-effectiveness and improve forecasting.
The US Healthcare System and Patient Compliance
Les Rose, (Mar 9, 2010)Richard Montwill, VP market strategy at Optum Health, on how improved adherence in the US can reduce waste and inefficiency.
Podcast: The Importance of Portfolio Planning
Andrew Tolve, (Mar 2, 2010)Bryan Stewart, vice president for international sales with Biomet, on the essence of expert portfolio management
Getting sales reps ready for specialty care roles
Lisa Roner, (Mar 2, 2010)Nicole Gaupset, national sales manager, hospital division, sanofi-aventis, on how to up-skill sales reps for the shift from primary to specialty care.
Improving sales efficiency and effectiveness
martin stuart smith, (Mar 2, 2010)Martin Stuart Smith on how an efficient, effective sales force can drive sales, market share and profits.
The State of Play in the Australian Pharma Sector
Andrew Tolve, (Mar 2, 2010)According to a new eyeforpharma survey, the Australian pharma industry is slow to adopt new sales and marketing models and wary of social media. Andrew Tolve reports
Podcast: Creating A Customer-centric Sales Force
Andrew Tolve, (Feb 26, 2010)Tyrone Edwards, professor of business administration at Cheyney University of Pennsylvania, on the need to put customers at the heart of selling
Press Release: Market Access USA 2010
Maria, (Feb 25, 2010)PHILADELPHIA – Today’s pharmaceutical companies face an unprecedented challenge of getting drugs to market and maintaining market share once there.
The link between marketing and market access
Marcus Deans, (Feb 25, 2010)Key factors for market access
Les Rose, (Feb 25, 2010)Ed Schoonfeld of ZS Associates offers tips for market access success, from scenario analysis to risk sharing.
User login
Events
Medical Devices & Diagnostics Sales & Marketing Europe
March 17-18, 2010 - London - Click here
Oncology USA
March 23-24, 2010 - Boston - Click here
Marketing Latin America
March 23-24, 2010 - Mexico City - Click here
Market Access & Government Opportunities Mexico
March 23-24, 2010 - Mexico City - Click here
R&D Innovation Europe
March, 2010 - Boston - days TBC
Oncology Market Access Europe
April 13-14, 2010 - London - Click here
SFE Europe
April 27-29, 2010 - Barcelona - Click here
Marketing Excellence and Analytics Conference
April 27-28, 2010 - Sydney - Click here
SFE USA
May 17-18, 2010 - Princeton - Click here
Medical Devices & Diagnostics Sales & Marketing USA
May 20-21, 2010 - Minneapolis - Click here
Marketing Excellence Japan
May 26-27, 2010 - Tokyo - Click here
Global Business Intelligence Summit
May, 2010 - Philadelphia - days TBC
Market Access Latin America
May, 2010 - Mexico City - days TBC
Sales Force Effectiveness & Market Excellence Brazil
May, 2010 - Sao Paulo - days TBC
Market Access USA
June 2-3, 2010 - Philadelphia - Click here
Forecasting Europe
June 8-9, 2010 - Zurich, Switzerland - Click here
Patient Adherence & Relationship Marketing Europe
June 16-17, 2010 - Zurich - Click here
Translational Medicine USA
June, 2010 - Boston - days TBC
Sales Force Effectiveness Japan
July 14-15, 2010 - Tokyo
Sales Excellence & Business Intelligence Australia
September 1, 2010 - Sydney - Click here
Oncology Japan
October, 2010 - Tokyo - days TBC
Managed Care USA
November, 2010 - Philadelphia - days TBC